Juvenile Dermatomyositis

• CLINICAL_TRIALS research · 2026-04-24
  Clinical Trial Update: FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM) [Phase 2]

  Phase 2 clinical trial evaluating fatty acid supplementation for Dermatomyositis and Juvenile Dermatomyositis is currently recruiting.

• CLINICAL_TRIALS research · 2026-04-24
  Clinical Trial Update: RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy [Phase 2, Phase 3]

  An open-label Phase 2/3 trial to evaluate the safety and efficacy of CABA-201 in active idiopathic inflammatory myopathy and related juvenil…

• CLINICAL_TRIALS research · 2026-04-20
  Clinical Trial Update: Environmental Risk Factors for the Anti-synthetase Syndrome

  This NIEHS-sponsored clinical trial investigates environmental risk factors for anti-synthetase syndrome, enrolling patients with inflammato…

• CLINICAL_TRIALS research · 2026-04-08
  Clinical Trial Update: Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders [Phase 1, Phase 2]

  Descartes-08 by Cartesian Therapeutics is in Phase 1/2 and currently recruiting for pediatric/young adult trials in childhood-onset systemic…

• CLINICAL_TRIALS research · 2026-04-06
  Clinical Trial Update: Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases Including Juvenile Dermatomyositis

  A NIAMS-sponsored clinical trial update announcing studies on the natural history, pathogenesis, and outcomes of autoinflammatory diseases, …

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2026-01-28
  Clinical Trial Update: MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)

  The MIHRA PRISMS clinical study for myositis is currently recruiting, sponsored by the Myositis International Health & Research Collaborativ…

• CLINICAL_TRIALS research · 2025-09-19
  Clinical Trial Update: Clinical Study of BCMA/CD70-targeted CAR-T Therapy for Refractory Pediatric Rheumatic Diseases [Phase 1]

  Phase 1 clinical trial evaluating a BCMA/CD70-targeted CAR-T therapy for refractory pediatric rheumatic diseases is currently recruiting.

• CLINICAL_TRIALS research · 2025-06-05
  Clinical Trial Update: Teams Engaged in Accessible Mental Health Interventions for Lupus Erythematosus and Dermatomyositis Stress [NA]

  Clinical trial status update about teams developing accessible mental health interventions for lupus erythematosus and dermatomyositis; the …

• CLINICAL_TRIALS research · 2024-11-13
  Clinical Trial Update: Clinical Study of CD19 Targeted Universal Chimeric Antigen Receptor T Lymphocytes (UCAR-T) for the Treatment of Refractory Juvenile Dermatomyositis (RJDM) [Phase 1]

  A Phase 1 trial is evaluating a CD19-targeted universal CAR-T therapy (UCAR-T) for refractory juvenile dermatomyositis and is currently recr…

• CLINICAL_TRIALS research · 2024-08-26
  Clinical Trial Update: Clinical Trial of CD19-targeted CAR-T Therapy for Refractory Juvenile Dermatomyositis [Phase 1]

  A Phase 1 trial is evaluating CD19-targeted CAR-T therapy for refractory juvenile dermatomyositis and is currently recruiting.

• CLINICAL_TRIALS research · 2018-02-27
  Clinical Trial Update: Juvenile Dermatomyositis

  This clinical trial update for Juvenile Dermatomyositis, sponsored by University Hospital in Strasbourg, France, shows an unknown status for…

• CLINICAL_TRIALS research · 2015-11-17
  Clinical Trial Update: The CARRA Registry

  The CARRA Registry study sponsored by Duke University has completed, documenting a broad range of juvenile rheumatic diseases, including Juv…

• CLINICAL_TRIALS research · 2012-01-16
  Clinical Trial Update: Creatine Supplementation in Pediatric Rheumatology [NA]

  This entry notes a clinical trial evaluating creatine supplementation in pediatric rheumatology, including Juvenile Systemic Lupus Erythemat…